Advertisement
Screener

NEUROPATHIX, INC. Increase (Decrease) in Derivative Liabilities

NEUROPATHIX, INC. Increase (Decrease) in Derivative Liabilities

NEUROPATHIX, INC. reported Increase (Decrease) in Derivative Liabilities of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-15.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2022-04-15

  • NEUROPATHIX, INC. increase (decrease) in derivative liabilities for the quarter ending 2020-12-31 was $0.00.
  • NEUROPATHIX, INC. increase (decrease) in derivative liabilities for the quarter ending 2020-09-30 was $0.00.
  • NEUROPATHIX, INC. increase (decrease) in derivative liabilities for the quarter ending 2020-06-30 was $458.02K.
  • NEUROPATHIX, INC. increase (decrease) in derivative liabilities for the quarter ending 2020-03-31 was $493.60K.
  • NEUROPATHIX, INC. increase (decrease) in derivative liabilities for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
  • NEUROPATHIX, INC. increase (decrease) in derivative liabilities for fiscal 2020 was $951.62K, a 431.38% increase from fiscal 2019.
  • NEUROPATHIX, INC. increase (decrease) in derivative liabilities for fiscal 2019 was $179.08K.
Period endIncrease (Decrease) in Derivative Liabilities 3 monthIncrease (Decrease) in Derivative Liabilities 6 monthIncrease (Decrease) in Derivative Liabilities 9 monthIncrease (Decrease) in Derivative Liabilities 12 month
2021-12-31$0.00
10-K · filed 2022-04-15
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
$0.00
derived: sum of 2 quarters · filed 2021-03-30
$458.02K
derived: sum of 3 quarters · filed 2021-03-30
$951.62K
10-K · filed 2021-03-30
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$458.02K
derived: sum of 2 quarters · filed 2020-11-12
$951.62K
10-Q · filed 2020-11-12
2020-06-30$458.02K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
$951.62K
10-Q · filed 2020-08-12
2020-03-31$493.60K
10-Q · filed 2020-05-14
2019-12-31$179.08K
10-K · filed 2020-03-30